|
|
Institutional Members Directory
 |
The Association of Clinical Research Organizations (ACRO) represents the world's leading global clinical research organizations (CROs). Our members provide specialized services that are integral to the development of drugs, biologics and medical devices. ACRO advances clinical outsourcing to improve the quality, efficiency and safety of biomedical research. Each year, ACRO’s members conduct thousands of clinical trials and provide related drug development services in more than 115 countries while ensuring the safety of nearly 2 million research participants.
Since our founding in 2002, ACRO has been committed to strengthening public understanding and confidence in clinical research and to highlighting CRO expertise in all aspects of the clinical research enterprise. ACRO represents the CRO industry globally to pharmaceutical, biotech and medical device companies, regulators and legislators, peer associations, academic organizations, patient groups, the media and the public. Read more... ACRO is a leading voice for safe and ethical clinical trials, working with stakeholders globally to explore new paradigms for research and development and to promote a better and more efficient clinical trial process. As such, the association looks to actively engage in EFGCP by supporting its mission and activities to ensure the highest ethical and scientific standards in clinical research globally.
www.acrohealth.org
|
 |
Clinical trials at university hospitals are increasingly important for the management of patients’ health.
It is a real challenge to conduct the trials in compliance with good clinical practice and research guidelines and regulations, in a scientific and technical environment which performs well because of a thorough organisation and qualified staff. This requires up-to-date knowledge and training opportunities for the institution and its staff. The Centre Hospitalier Universitaire Brugmann finds that the EFGCP activities create a stimulating environment which helps it fulfill its research mission.
Read more... ACRO is a leading voice for safe and ethical clinical trials, working with stakeholders globally to explore new paradigms for research and development and to promote a better and more efficient clinical trial process. As such, the association looks to actively engage in EFGCP by supporting its mission and activities to ensure the highest ethical and scientific standards in clinical research globally.
www.uvc-brugmann.be
|
 |
The European Medical Writers Association (EMWA) was founded in 1989 with the primary aim of providing a forum to promote standards of excellence in medical writing by furthering professional development through training. EMWA currently has nearly 900 members working either in-house or freelance in the pharmaceutical industry, contract research or medical communications field involved with regulatory writing, translation and writing for the public.
The EMWA Professional Development Programme (EPDP) is one of a few opportunities available to obtain a qualification in medical writing. EMWA consider it important to ensure that the EPDP certification is regarded as a valuable qualification by the medical writing community, employers and clients. To achieve this, the EMWA Professional Development Committee (EPDC) strives to deliver high quality training workshops for which credits are awarded to participants who also successfully complete pre and post-workshop assignments. Workshops are provided by experienced writers and specialists in their field who do so without remuneration Read more... The EPDC selects workshops to cater for a broad audience of writers; workshop content is assessed and the programme adapted to meet the needs of EMWA members. All workshops are evaluated by participants to verify their quality and usefulness. Workshops are currently offered in the following areas: Drug Development e.g. protocol & report writing, good clinical practice, ethics and regulatory guidance; Language and Writing e.g. improving English usage, editing & proof-reading, medical & pharmaceutical English for non-native speakers; Medical Science e.g. pharmacology, epidemiology and pharmacogenetics; Medical Communication e.g. publication planning & strategy, preparing medical communication documents, conference & meeting reporting; Professional Techniques e.g. data presentation techniques, presenting statistics, using data sources and medical writing software, and Soft Skills e.g. interpersonal skills and training methods. After successfully completing eight workshops participants can obtain an EPDP specialised or multidisciplinary certificate at either the foundation or advanced level.
EMWA holds conferences twice a year in various European cities; a five day Spring and a two day Autumn meeting. Spring conference themes have included Regulatory Writing and Scientific & Medical Translation. At these conferences short workshops, seminars and plenary lectures by invited speakers are offered in addition to the EPDP to keep EMWA members up to date with the current trends and regulations.
EMWA’s other aims include providing professional and social networking opportunities, and increasing awareness of medical writing throughout Europe. These aims are met by the provision of the EMWA journal 'The Write Stuff' which is published four times a year; the EMWA website which hosts information about forthcoming conferences and training, job advertisements and freelance opportunities; and by establishing links with other organisations, e.g. The Institute of Clinical Research, to increase awareness of medical writing within the broader clinical research community and to provide cross-function training opportunities.
www.emwa.org
|
 |
The European Organisation for Research and Treatment of Cancer (EORTC) was founded as an international organisation under Belgian law in 1962 by eminent oncologists working in the main cancer research institutes of the European Union countries and Switzerland. It was named the Groupe Européen de Chimiothérapie Anticancéreuse (GECA), and became the EORTC in 1968.
The aims of the EORTC are to develop, conduct, coordinate, and stimulate translational and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patient quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individual European hospitals, and can best be accomplished through the multidisciplinary multinational efforts of basic scientists and clinicians. Read more... The ultimate goal of the EORTC is to improve the standard of cancer treatment through the testing of more effective therapeutic strategies based on drugs, surgery and/or radiotherapy that are already in use and also through the development of new drugs and other innovative approaches. This is accomplished mainly by conducting large, multicentre, prospective, randomised, phase III clinical trials. In this way, the EORTC facilitates the passage of experimental discoveries into state-of-the-art treatments.
The EORTC Headquarters is based in Brussels, Belgium, from where its various activities are coordinated and run. However, the EORTC is both multinational and multidisciplinary, and the present EORTC Network comprises over 300 hospitals or cancer centers in over 30 countries, which include:
• some 2,900 collaborators from all disciplines involved in cancer treatment and research;
• some 6,000 new patients who are enrolled each year;
• some 50 trials that are permanently open to patient entry;
• some 50,000 patients who are in follow-up;
• a database of more than 180,000 patients.
Through translational and clinical research, the EORTC offers an integrated approach to drug development, drug evaluation programs and medical practices.
The EFGCP and the EORTC share common interests and have worked together developing and conducting workshops and conferences promoting good clinical practice.
www.eortc.be
|
 |
ESA resulted from the amalgamation of the former European Society of Anaesthesiologists (ESA), the European Academy of Anaesthesiology (EAA) and the Confederation of European National Societies of Anaesthesiologists (CENSA) and holds the most prominent position in the community of anaesthesiologists in Europe and elsewhere with more than 4000 individual members and more than 32 National Anaesthesia Societies representing more than 75.000 anaesthetists in Europe. The Society is governed by a Board of Directors, a Council and the General Assembly.
Its mission statement is to aim for the highest standards of practice and safety in anaesthesia, intensive care, emergency medicine and pain treatment through education, research and professional development throughout Europe. Read more... The aims of the Society are:
- To promote exchange of information between European anaesthesiologists,
- To disseminate information in regard to anaesthesiology,
- To raise the standards of the speciality by fostering and encouraging education, research, scientific progress and exchange of information,
- To promote and protect the interest of its members,
- To promote improvements in safety and quality of care of patients who are under the care of anaesthesiologists inside and outside the operating room by facilitating and harmonising the activities of national and international societies of anaesthesiologists in Europe.
ESA is also establishing a Clinical Translational Research Network (CTN) in order to provide an infrastructure that allows improving the care of patients in the fields of anaesthesia, pain, intensive care and emergency medicine through transnational European collaborative investigations. The ESA CTN is managed by the ESA Research Committee in collaboration with the ESA Scientific Programme Committee and the National Anaesthesia Societies Committee, and will report to the ESA Board for its actions and activities.
ESA is organising the European Diploma in Anaesthesiology and Intensive Care Medicine (EDA) throughout Europe in 11 European languages in more than 20 Examination centres. It is a multilingual, end-of-training, two-part examination covering the relevant basic sciences and clinical subjects appropriate for a specialist anaesthesiologist. In Several European countries, the EDA Part I Exam is a mandatory Exam for the specialisation of Anaesthesiologist.
Finally, ESA organises the European Anaesthesiology Congresses throughout Europe under the banner EUROANAESTHESIA. These meetings are attended by members and non-members representing more than 80 countries from around the world. The European Anaesthesiology Congresses offer a comprehensive scientific programme of refresher course lectures, symposia and workshops, together with presentation and discussion of the latest research undertaken in Europe in particular. The European Anaesthesiology Congresses are accredited by the U.E.M.S./EACCME for C.M.E. credits. More than 6000 delegates attend the congress every year and more than 100 exhibitors participate in the industrial exhibition at the Euroanaesthesia Annual Meeting each year.
ESA choose to join the EFGCP to access to the leading European and international discussions on ethics and science in clinical research, to facilitate the transfer of knowledge and skills across disciplines and sectors, and to enhance cooperation through networking and partnerships opportunities within the clinical research community.
www.euroanaesthesia.org
|
 |
The European CRO Federation (EUCROF) created in 2005, represents and promotes CROs located in Europe (9 countries, 250 CROs). Its objectives are to communicate with Clinical Research Stakeholders and to improve knowledge, competence and skills of CROs located in Europe by,
- Maintaining a legal entity to represent the interests of CROs in Europe in relation with the regulatory bodies, the pharmaceutical and biotech industry, the medicinal and research community and the patients’ associations;
- Contributing to the development of international legislation applicable to the research community throughout Europe and beyond;
- Promoting exchange of information between members;
- Promoting and supporting high quality clinical research;
- Developing training and educational programs for clinical research;
- Organizing International congresses.
Read more...
EUCROF has created 5 working groups among which the paediatric group is working very actively in collaboration with EMA, national authorities, and EFGCP. The paediatric working group has published several articles on surveys run in various countries and is working on establishing training sessions to improve paediatric clinical trials.
www.eucrof.eu
|
|